Regeneron says antibody cocktail cuts COVID-19 risk for up to eight months

Regeneron’s antibody cocktail cut the risk of contracting COVID-19 by 81.6 percent in the two to eight months after the cocktail’s administration, the pharmaceutical company announced on Monday. A single dose of the cocktail, a…